BriaCell to Present Clinical Findings at the 2020 San Antonio Breast Cancer Symposium®, December 9 - 11 Biotech Investing
Amgen Announces Positive Topline Phase 2 Results For Investigational KRAS G12C Inhibitor Sotorasib In Advanced Non-Small Cell Lung Cancer Biotech Investing
Alert: Johnson Fistel Investigates Proposed Sale of MyoKardia; Is $225 a Fair Price? Biotech Investing
Trillium Therapeutics Receives Notices of Allowance From U.S. Patent and Trademark Office Biotech Investing
Gilead Presents Biktarvy® Findings From Switch Studies & Analysis of Real-World BICSTaR Study At HIV Glasgow 2020 Biotech Investing
Amgen Announces Five-Year Data That Reinforce The Safety And Efficacy Profile Of Aimovig® In Adult Patients With Episodic Migraine Biotech Investing
Bristol Myers Squibb Announces Update on CheckMate -915 Evaluating Opdivo Plus Yervoy Versus Opdivo in Resected High-Risk Melanoma Patients Biotech Investing
U.S. Food and Drug Administration Approves Opdivo® + Yervoy® as the First and Only Immunotherapy Treatment for Previously Untreated Unresectable Malignant Pleural Mesothelioma Biotech Investing
